By Eddie Khoriaty, BPharm, R.Ph., C.Ph.
Starting a GLP-1 medication can feel like learning a new language. You may hear names like Ozempic, Wegovy, Mounjaro and Zepbound, along with terms such as semaglutide, tirzepatide and GIP. Which names refer to the same ingredient? Why are some products used for diabetes and others for weight management?
Here is the short answer to what these medications are: they are prescription drugs that act on hormone signals involved in blood sugar, appetite and digestion. Some medications mimic the action of GLP-1, a hormone your body releases after you eat. Others, including tirzepatide, act on GLP-1 and another hormone pathway called GIP. The differences matter when you are trying to understand exactly what you have been prescribed.
I understand the confusion from both sides. I have spent more than 30 years as a pharmacist helping people make sense of their medications, and I also have personal experience with this class of drugs.
Once you know the name of your medication, the questions become more practical. Why am I full after only a few bites? Am I drinking enough? How do I get enough protein when I am not hungry? Is this stomach symptom expected? Am I losing muscle along with fat?
Those questions matter. A prescription label can tell you how to take a medication, but it cannot plan your meals or help you recognize when a symptom deserves a call to your healthcare provider.
I wrote this guide as a starting point for those conversations. It will help you understand how these medications differ, what to watch for as you begin and what to ask your healthcare team. Your prescriber should guide decisions about which medication to use and when to change your dose.
Start Here
GLP-1 is a hormone your body naturally produces. It plays a role in blood sugar regulation, appetite, fullness and digestion.
Not every medication called a “GLP-1” works in exactly the same way. Some act on one hormone pathway, while others act on two or three.
Semaglutide and tirzepatide are different medications. They have different actions, dosing instructions and approved uses.
Digestive symptoms are common. They may be more noticeable when treatment begins or after the dose increases.
A smaller appetite does not mean your body needs less nutrition. Protein, fluids and nutrient-dense foods still matter.
Successful treatment is about more than the scale. Preserving muscle, strength, energy and overall health should remain part of the plan.
Starting a GLP-1? Jump to the free Start Smart Checklist ↓
GLP-1 stands for glucagon-like peptide-1. It is a hormone your body naturally releases after you eat. Among other things, it helps the pancreas release insulin when blood sugar is elevated, reduces glucagon activity when appropriate, slows how quickly food leaves the stomach and sends signals to the brain that contribute to fullness.
That last part is important. Appetite is influenced by the brain, digestive system, hormones, habits, environment and emotions. It is not a character test, and it is not controlled by willpower alone.
GLP-1 medications are designed to activate some of the same signaling pathways your body already uses. As a result, people may feel full sooner, stay full longer and experience less hunger. The medications can also affect blood sugar and digestion.
They do not simply “burn fat.” They change the signals involved in appetite, fullness, blood sugar and the movement of food through the digestive system. That is why their effects can extend well beyond the number on the scale. It is also why nutrition, hydration and medication timing deserve attention from the beginning.
Curious how this science became a medication? Read How the Gila Monster Revolutionized Appetite Control to discover how an unlikely reptile helped change diabetes and weight-management treatment.
“GLP-1” has become an umbrella term for several medications that affect appetite, blood sugar and digestion. It makes conversation easier, but it can also hide some important differences between the drugs.
Single agonists act primarily on the GLP-1 receptor. Semaglutide, liraglutide and dulaglutide are examples.
Dual agonists activate two hormone pathways. Tirzepatide acts on both GIP and GLP-1 receptors.
Triple agonists are designed to activate three pathways. Retatrutide targets GIP, GLP-1 and glucagon receptors.
You may see retatrutide called “GLP-3” online. It is a catchy nickname, but it is not technically correct. A triple agonist is one medication acting on three receptor systems, not a newer numbered version of GLP-1.
Retatrutide remains investigational. It is being studied in Phase 3 clinical trials, but it is not FDA approved or available for public use. Positive study results do not make a medication approved, and products advertised as retatrutide outside a legitimate clinical trial should be treated with caution.
Know Your Medication
One of the best medication-safety habits is learning both the generic and brand names of what you take. The same active ingredient may be sold under different brand names, in different forms, for different approved uses.
| Generic name | Common brand names | Medication type | How it is taken | Examples of FDA-approved uses* |
|---|---|---|---|---|
| Semaglutide | Ozempic, Wegovy, Rybelsus Wegovy comes as an injection and a pill | GLP-1 receptor agonist | Weekly injection (Ozempic, Wegovy) or daily tablet (Rybelsus, Wegovy pill) | Depending on the product: type 2 diabetes, chronic weight management, cardiovascular risk reduction, kidney-related risk reduction in adults with type 2 diabetes and chronic kidney disease, and certain cases of MASH |
| Orforglipron | Foundayo | Oral GLP-1 receptor agonist | Daily tablet | Chronic weight management in adults with obesity, or adults with overweight and at least one weight-related health condition |
| Tirzepatide | Mounjaro, Zepbound | Dual GIP and GLP-1 receptor agonist | Weekly injection | Depending on the product: type 2 diabetes, chronic weight management and moderate-to-severe obstructive sleep apnea in adults with obesity |
| Liraglutide | Victoza, Saxenda Generic versions available | GLP-1 receptor agonist | Daily injection | Depending on the product: type 2 diabetes, cardiovascular risk reduction and chronic weight management |
| Dulaglutide | Trulicity | GLP-1 receptor agonist | Weekly injection | Type 2 diabetes and reduction of certain major cardiovascular risks in appropriate patients |
| Retatrutide | No approved brand name | Triple GIP, GLP-1 and glucagon receptor agonist | Weekly injection in clinical trials |
No FDA-approved uses. Several Phase 3 trials have reported
positive results, and FDA review is expected to be requested
in 2027.
Investigational |
Semaglutide
Ozempic, Wegovy, Rybelsus
Orforglipron
Foundayo
Tirzepatide
Mounjaro, Zepbound
Liraglutide
Victoza, Saxenda (generic versions available)
Dulaglutide
Trulicity
Retatrutide
No approved brand name
*This is a simplified overview, not a complete list of indications, formulations or approved age groups. Approval status and labeling can change over time. Chart last reviewed September 2026.
The same generic ingredient can be sold under different brand names for different approved purposes. Ozempic and Wegovy both contain semaglutide, but that does not make the brands interchangeable. Mounjaro and Zepbound both contain tirzepatide, but their labeling and approved uses differ. Brand, strength, formulation, dose and intended use all matter.
Even a single brand name can cover very different products. Wegovy is available as a weekly injection and as a daily pill, and the doses are not the same. Oral GLP-1 medications also differ in how they are taken. The Wegovy pill and Rybelsus must be taken on an empty stomach with a small amount of water, followed by a wait before eating, drinking or taking other medicines. Foundayo can be taken at any time of day, with or without food. Follow the instructions for your exact product.
If you are not sure what you take, do not rely on saying “my GLP-1.” Look at the prescription label, medication box or patient portal and write down the exact generic name, brand name, form and strength.
Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on two receptors, GLP-1 and GIP. Both can affect appetite, blood sugar and digestion, but they are different medications with their own dosing instructions, side effects and approved uses.
You may know semaglutide by the brand names Ozempic or Wegovy, and tirzepatide by Mounjaro or Zepbound. A shared ingredient does not mean the brand names can be used interchangeably. The product, dose and reason it was prescribed all matter.
If you are considering a switch, ask your prescriber what will change and when to take your next dose. Do not use your current dose as a guide for the new medication.
Compounding has an important place in pharmacy. If someone cannot use an approved medication because of an allergy to an ingredient, for example, a pharmacist may be able to prepare a version that meets that person’s needs. Compounded GLP-1 medications became much more common when approved semaglutide and tirzepatide products were in short supply.
Those shortages have been resolved. That does not mean all GLP-1 compounding is prohibited, but the shortage alone is no longer a reason to make copies of the approved products.
The distinction I want you to understand is this: a compounded GLP-1 medication is not FDA-approved. Unlike an approved product, it has not gone through FDA review for safety, effectiveness and quality before reaching patients. That does not tell us whether any particular vial is good or bad. It does mean you should know who prescribed it, who prepared it and exactly what you received.
Dosing deserves special attention. Some compounded injections come in multi-dose vials that require you to draw up each dose with a syringe. The medication may be prescribed in milligrams, while the syringe is marked in units. The number of units depends on the concentration in your vial. It can change if you receive a different strength or switch pharmacies. The FDA has received reports of people taking too much compounded semaglutide because the instructions or measurements were misunderstood. Some needed hospital care.
The ingredient matters, too. The FDA has warned about products made with semaglutide sodium or semaglutide acetate. Those salt forms are different active ingredients from the semaglutide used in approved medications. You may also see compounded products combined with vitamin B12 or other ingredients. Do not assume that adding a vitamin makes the medication safer or more effective.
I would be especially cautious of vials sold online as “research peptides” or marked “not for human use.” Those labels are a warning, not a workaround for getting a prescription.
Many people started with a compounded medication because the approved product was unavailable or too expensive. If that includes you, take a few minutes to check the details:
If you cannot tell exactly how much to draw up, call the dispensing pharmacy or your prescriber before your next dose. For general questions about GLP-1 medications, you can also Ask the Pharmacist.
Some people notice that hunger comes less often. Others feel full after only a few bites, lose interest in foods they used to enjoy or find that their usual portion suddenly feels uncomfortable. Thoughts about food may become quieter, and cravings can change.
That can be helpful, but it also creates a new responsibility. A smaller appetite does not mean your body needs less nutrition. It is possible to eat too little without realizing it, especially when early weight loss makes a very low food intake seem like success.
I encourage people to replace “How little can I eat?” with “How can I meet my needs with the appetite I have now?”
That change in thinking matters. When you cannot eat as much, the food you do eat has to work harder. Protein, fluids and nutrient-dense foods become more important, not less. If you regularly struggle to eat enough, feel weak or lightheaded, or lose weight faster than expected, let your healthcare provider know.
Read next: Taking a GLP-1? Here Are 5 Side Effects Nobody Warned You About
Digestive symptoms can develop for several reasons. These medications may slow how quickly food leaves the stomach. At the same time, people may continue serving the same portions they ate before treatment, even though the amount that feels comfortable has changed. Large, rich or high-fat meals may suddenly become much harder to tolerate.
Common complaints include nausea, constipation, diarrhea, bloating, vomiting, indigestion and abdominal discomfort. Symptoms may be more noticeable when treatment begins or after the dose is increased. That does not mean every symptom should automatically be blamed on the medication or ignored.
The answer is not always to eliminate more and more foods. Start by looking for patterns. How large was the portion? How quickly did you eat? Was the meal especially rich or high in fat? How much fluid had you consumed? Had your bowel habits changed? Did the symptom appear shortly after your dose?
A short record of what happened is much more useful to your healthcare provider than simply saying, “My stomach hasn’t felt normal.” Include when the symptom began, what you ate, your medication dose, your fluid intake and any changes in bowel habits.
For more focused help, read Why Am I Constipated?, Why Am I So Bloated?, and How to Choose a Probiotic.
GLP-1 receptor activation helps the pancreas release insulin when blood sugar is elevated. These medications also affect glucagon, a hormone that helps the liver release stored glucose. Slower digestion can influence how quickly blood sugar rises after a meal.
The risk of low blood sugar is not the same in every situation. It can be higher when a GLP-1 medication is combined with insulin or an insulin-releasing drug such as a sulfonylurea.
If you take medication for diabetes, ask your prescriber whether your treatment or glucose-monitoring plan needs to change. Do not reduce insulin, skip another diabetes medication or change a dose on your own. A medication adjustment may be appropriate, but that decision should be made with the healthcare professional managing your diabetes.
No two people follow exactly the same timeline. A friend’s dramatic first week does not predict how you will respond, and feeling very little at first does not automatically mean the medication is not working.
Make sure you know exactly what you are taking and how you are expected to use it.
You may notice less hunger, earlier fullness, nausea or other digestive changes. You may also feel very little at first.
An immediate or dramatic response is not required for the medication to be working. Give your body time to respond, and avoid comparing your first week with someone else’s experience.
Many GLP-1 medications begin at a lower dose and increase gradually. This gives your body time to adjust and may help reduce digestive side effects.
Symptoms may return or become more noticeable after an increase. Do not move through the dosing schedule faster on your own. Depending on the medication and how you respond, your prescriber may decide to delay an increase or keep you at the current dose longer.
The goal is not to reach the highest dose as quickly as possible. The right dose is the one your prescriber determines is appropriate based on your response, treatment goals and side effects.
Your weight is only one part of the picture. Also pay attention to your energy, strength, protein and fluid intake, digestive symptoms, bowel habits, blood sugar if you have been instructed to monitor it, and your ability to complete normal daily activities.
Free Two-Page Printable
Keep your medication details, dose instructions, symptoms and questions organized in one place. The GLP-1 Start Smart Checklist helps you prepare for your first dose, a dose increase or your next appointment.
Enter your email below and we’ll send the printable directly to your inbox.
You do not need a perfect “GLP-1 diet.” You need a way of eating that supplies enough nutrition, fits your medical needs and feels tolerable.
Begin with modest portions and eat slowly enough to notice fullness before it becomes discomfort. If a full meal feels overwhelming, smaller meals or snacks spaced throughout the day may work better. Include a source of protein regularly and choose foods you can comfortably tolerate.
When your appetite is reduced, every bite has to do a little more work.
I do not like calling foods “good” or “bad.” Those labels create guilt but tell us very little about portion size, frequency, tolerance or nutritional value. The goal is not to punish yourself. It is to learn what your body needs and how it responds now.
If you are routinely unable to eat enough, are losing weight very quickly or are avoiding entire food groups because of symptoms, ask for help. A registered dietitian can be especially valuable. People with diabetes, kidney disease, heart disease, digestive disorders or other medical conditions may need more individualized guidance.
Helpful resources: How to Preserve Muscle While Losing Weight, the Hidden Sugar Food Label Checklist and the Muscle-Preserving Weight Loss Checklist.
When appetite fades, drinking habits sometimes fade with it. Nausea, vomiting or diarrhea can increase fluid loss, while eating and drinking less can make constipation worse.
Sip fluids regularly rather than waiting until you feel very thirsty or trying to drink a large amount all at once. Keep a bottle where you can see it. Darker urine can sometimes suggest that you need more fluid, but it is not a perfect measure. Medicines, vitamins, foods and medical conditions can also change urine color.
Electrolyte products are not automatically necessary. Some contain meaningful amounts of sodium, potassium or sugar. That may matter if you have high blood pressure, heart failure, kidney disease, diabetes or a prescribed fluid restriction. Ask whether an electrolyte product is appropriate for you rather than assuming everyone taking a GLP-1 needs one.
If your bowel pattern changes, keep a brief record. Dates, frequency, stool changes, pain, fluid intake and possible food triggers are worth noting. The Digestive Regularity Tracker can help you keep those details organized.
This is one of the most important and most overlooked parts of the journey. If there is one point I want to emphasize, it is the importance of eating enough protein and continuing to use your muscles.
Weight loss is not automatically pure fat loss. It can also include lean tissue. That deserves attention at every age, but it becomes especially important as we get older.
Muscle is not only about appearance. It helps you climb stairs, carry groceries, get up from a chair, maintain your balance and remain independent. A lower number on the scale is not a complete victory if it comes with preventable weakness.
Regular protein intake, resistance exercise and adequate recovery can help support muscle. The right amount of protein and the right exercise plan depend on your body size, kidney function, health conditions, fitness level and goals. Anyone with medical or physical limitations should ask for individualized guidance.
As someone who values resistance training, I think strength gives us a useful reality check. Can you still do what you could do a month ago? Are ordinary tasks becoming easier or harder? Those answers may tell you more than a single reading on the scale.
Continue with How to Preserve Muscle While Losing Weight, Sarcopenia: Why We Lose Muscle as We Age and the Muscle-Preserving Weight Loss Checklist .
There is no universal “GLP-1 supplement stack.” Supplements do not replace food, fluids or medical care, and having a smaller appetite does not automatically mean you need a long list of vitamins.
Some supplements can worsen nausea, constipation or diarrhea. Others can interact with medications, affect blood sugar or duplicate ingredients you already take. GLP-1 medications can also delay stomach emptying, which may affect how certain oral medications are absorbed.
Give your pharmacist or prescriber a complete list of everything you use. Include prescription drugs, over-the-counter medicines, vitamins, herbs, fiber products, protein powders, electrolyte products and anything marketed for glucose control or weight loss. Product names, ingredient lists and doses are more useful than saying you take “a vitamin” or “something natural.”
Be especially skeptical of products promoted as “natural Ozempic,” “GLP-1 boosters” or replacements for prescription treatment. Most are using the popularity of these medications as a marketing strategy. “Natural” does not automatically mean effective, necessary or free of risk.
Delayed stomach emptying is one reason certain oral medications may need extra attention. Birth control pills are an important example.
The prescribing information for tirzepatide (Mounjaro and Zepbound) advises people who use oral hormonal birth control to switch to a non-oral method, or to add a barrier method such as condoms, for 4 weeks after starting treatment and for 4 weeks after each dose increase. Other methods, such as an IUD, implant, injection, patch or ring, are not taken by mouth, so this concern does not apply to them in the same way.
Vomiting and diarrhea can also make any birth control pill less reliable, regardless of which medication caused them. If you use the pill and are having these symptoms, ask your pharmacist whether you need backup protection.
If you use hormonal birth control and are starting any GLP-1 medication, ask your prescriber or pharmacist whether your current method is the right fit. Mention it again before each dose increase.
Know When to Call
Digestive side effects are common, particularly when treatment begins or the dose increases. What matters is knowing when a symptom is manageable and when it should not be ignored.
These symptoms are frequently reported with GLP-1 medications. They may improve as your body adjusts, but let your healthcare provider know if they are persistent, worsening or difficult to manage.
You do not need to ask every question at one appointment. Choose the ones that apply to you, save the rest and bring the list whenever your treatment is reviewed.
Medication safety reminder: Do not start, stop, combine, increase or decrease a GLP-1 medication without instructions from the healthcare professional managing your prescription.
It's easy to let the scale become the loudest voice in the room. I would rather see it become one part of a much larger conversation.
Progress may include improved blood sugar, a smaller waist, easier movement, better cardiovascular risk factors, more energy, better sleep or a calmer relationship with food. Preserving strength and muscle belongs on that list, too. A lower number on the scale is not a complete success if you are becoming weaker, struggling to eat enough or no longer feeling well.
At some point, continued weight loss may no longer be the healthiest goal. Maintenance is not failure. It may be the stage when you protect your strength, nutrition and the progress you have already made.
My pharmacist training makes me careful about medication safety, but personal experience has made me equally aware of the space between a prescription and everyday life. People tend to do better when they understand what they are taking, know what to watch for and feel comfortable asking questions early.
You do not need to become a medication expert. You need reliable information, a plan that supports your whole health and a healthcare team willing to listen.
Continue reading: When to Stop Losing Weight on GLP-1s
GLP-1 stands for glucagon-like peptide-1. It is a hormone your body naturally produces that plays a role in blood sugar regulation, appetite, fullness and digestion.
It is often placed under the “GLP-1” umbrella in everyday conversation, but tirzepatide is technically a dual GIP/GLP-1 receptor agonist. It activates two hormone pathways rather than GLP-1 alone.
Semaglutide activates the GLP-1 receptor. Tirzepatide activates both GIP and GLP-1 receptors.
They are different medications with different dosing schedules, product labeling and instructions. They should not be treated as interchangeable.
No. A compounded version might contain the same active ingredient, a salt form of it, or a mix with added vitamins, and it has not gone through FDA approval. If you use one, find out exactly what is in it and what your dose is in milligrams. Your pharmacist can help you read the label.
No. Many commonly used GLP-1 medications are injections, but oral options are also available. Rybelsus contains oral semaglutide, and other tablet formulations have entered the market.
How and when an oral medication is taken can affect how well it is absorbed, so follow the instructions for your exact product rather than assuming all GLP-1 tablets are taken the same way.
No. A triple agonist is one medication designed to act on three receptor systems. Retatrutide, for example, targets GIP, GLP-1 and glucagon receptors.
“GLP-3” is a nickname sometimes used online, but it is not the correct scientific name for this type of medication. As of this writing, Retatrutide remains investigational and is not currently FDA approved.
The medication begins acting after it is taken, but what you notice and when you notice it can vary. Some people experience appetite or digestive changes early. Others feel very little at the starting dose.
These medications are generally evaluated over time and through the prescribed dose-escalation schedule. A dramatic first-week response is not required for the medication to be working.
A higher dose may have a stronger effect on appetite and digestion. Nausea, fullness, constipation, diarrhea or abdominal discomfort may return or become more noticeable while your body adjusts.
If symptoms are persistent, severe or getting worse, contact your prescriber before taking the next step in your dosing schedule.
There is no single GLP-1 diet that is right for everyone. Modest portions, slower eating, adequate fluids, regular protein and foods you tolerate are sensible places to begin.
Your medical history also matters. Diabetes, kidney disease, heart disease and digestive conditions may change what is appropriate for you.
There is no single number that works for every person. Protein needs vary based on age, body size, activity, weight-loss goals and medical conditions, particularly kidney disease.
Ask your healthcare provider or a registered dietitian to help you choose an appropriate target. The important thing is not to let a smaller appetite push protein completely out of your day.
Possibly, but it depends on the supplement, dose, other medications, health conditions and symptoms. Some supplements can worsen nausea, constipation or diarrhea. Others may affect blood sugar or duplicate ingredients you are already taking.
Give your pharmacist or prescriber a complete list that includes vitamins, herbs, fiber products, electrolyte mixes, protein powders and anything marketed for glucose control or weight loss.
The answer should consider more than BMI or a target clothing size. Look at your strength, energy, nutritional intake, physical function, laboratory results, health goals and overall wellbeing.
If you are becoming weaker, struggling to eat enough or continuing to lose weight beyond your intended goal, talk with your prescriber about whether it is time to focus on maintenance.
For additional information, read our article, When to Stop Losing Weight on GLP-1s.
Missed-dose instructions differ by medication and product. Check the instructions supplied with your prescription or contact your pharmacist or prescriber.
Do not double the next dose unless the instructions for your exact medication specifically tell you to do so.
Have a general wellness or medication question? Ask Eddie, our pharmacist.
Please keep your question general and do not include private medical details. This form is not monitored for urgent concerns. If you need advice about a symptom, prescription or dose, contact your own healthcare provider or dispensing pharmacist. For a medical emergency, call 911.
Starting a GLP-1 medication or preparing for a dose increase? Use the free, pharmacist-guided Start Smart Checklist to organize your medication details, confirm instructions with your care team, and prepare questions.
Get the Free Start Smart ChecklistThe information provided in this article is intended for educational purposes only and should not be considered medical advice. It is not intended to diagnose, treat, cure, or prevent any disease, or to replace the advice of your physician or other qualified healthcare provider.
Always consult your healthcare provider before making changes to your diet, exercise routine, medications, or supplement regimen, especially if you have a medical condition, are pregnant or nursing, or take prescription medications.
Individual health needs vary, and the information presented may not be appropriate for every person.
